glp-1 migraine glp 1 migraines Drug Cuts Days in Half A new study finds that GLP-1 diabetes drugs like Ozempic
Description
For many years, the GLP-1 drug market was dominated by injectable therapies such as Semaglutide and Tirzepatide
[17] In January 2023, the US FDA prescription label for Rybelsus was updated to reflect that it can be used as a first-line treatment for adults with type 2 diabetes
By synthesizing trial outcomes, labeling guidance, and clinical practice considerations, this comparison supports providers in determining which medication aligns best with an individual patients metabolic profile, treatment goals, and risk factors
Starting with a lower dose or slower titration schedule can minimize side effects
